98 results
Page 4 of 5
6-K
47row4 y09fgqx
15 Jan 20
Current report (foreign)
8:35pm
6-K
EX-99.1
dirpa1oiv
10 Dec 19
ObsEva Announces Positive Results from Uterine Fibroids Phase 3 Study (PRIMROSE 2) of Linzagolix
12:00am
6-K
EX-99.2
6xa 043et8wesfx59ek3
10 Dec 19
ObsEva Announces Positive Results from Uterine Fibroids Phase 3 Study (PRIMROSE 2) of Linzagolix
12:00am
6-K
EX-99.2
ign7v
13 Nov 19
Index to Unaudited Condensed Consolidated Financial Statements
4:00pm
F-3
EX-4.1
yq2bn6qh lmdk2a
7 Aug 19
Shelf registration (foreign)
8:24am
F-3
pqy5rcmf92bon6ib2
7 Aug 19
Shelf registration (foreign)
8:24am
424B5
vk4d dt1imxv
7 Aug 19
Prospectus supplement for primary offering
8:18am
6-K
EX-99.1
x1k20 rr1zds5ckyc0c9
7 Aug 19
Current report (foreign)
7:21am
6-K
EX-99.2
dz5s8ffomw
7 Aug 19
Index to Unaudited Condensed Consolidated Financial Statements
6:04am
6-K
EX-3.1
9e92km
20 May 19
Current report (foreign)
5:28pm
6-K
EX-99.2
4msi5w9ovtk574
9 May 19
Index to Unaudited Condensed Consolidated Financial Statements
6:05am
6-K
EX-99.2
0dewube
8 Nov 18
Index to Unaudited Condensed Consolidated Financial Statements
9:28am
6-K
kfdv3lgb
28 Sep 18
Current report (foreign)
8:40am
6-K
EX-99.2
7oxvt4 2t5q4lds6
8 Aug 18
Index to Unaudited Consolidated Interim Financial Statements
7:00am
6-K
h3sbwz2 xyiw4
25 Jul 18
Current report (foreign)
8:21am
6-K
1xcpvnwwsc5 3xwt4i
6 Jul 18
Current report (foreign)
7:42am
424B5
elt9 1qpak
20 Jun 18
Prospectus supplement for primary offering
5:32pm
424B5
pra5l8a0
18 Jun 18
Prospectus supplement for primary offering
9:15pm